← Latest Filings
K

Kenney Christopher John

Chief Medical Officer

Open-market buys
0
$0 total
Open-market sells
4
$670K total
Tracking since
Mar 2026
Open-market sale — $43K
Open-market sale — $383K
Open-market trades from the last two years.
100,000 Share Option (Right to Buy) in XENE
Held directly · as of 2026-01-09
20,000 Restricted Share Units in XENE
Held directly · as of 2026-01-09
Xenon Pharmaceuticals Inc.
CIK 0001582313